http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (HealthDay)—In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has superior efficacy, according to a study published in the Feb. 7 issue of the New England Journal of Medicine. http://medicalxpress.com/news/2013-02-rivaroxaban-noninferior-enoxaparin-acutely-ill.html Diseases, Conditions, Syndromes Thu, 07 Feb 2013 11:20:02 EST news279457844 The clot-inhibiting drug apixaban (trade name: Eliquis) was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined the added benefit of apixaban. http://medicalxpress.com/news/2012-09-proof-added-benefit-apixaban-hip.html Medications Mon, 17 Sep 2012 10:53:40 EST news267098004 (HealthDay) -- For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is significantly higher in those treated with enoxaparin compared to those treated with desirudin, according to a study published online June 4 in the Journal of Thrombosis and Haemostasis. http://medicalxpress.com/news/2012-06-higher-vte-ckd-surgical-patients.html Diseases, Conditions, Syndromes Fri, 08 Jun 2012 12:30:01 EST news258376565 The anticoagulant dabigatran is associated with an increased risk of myocardial infarction (heart attack) or acute coronary syndrome in a broad spectrum of patients when tested against some other medicines, according to a study published Online First by the Archives of Internal Medicine. http://medicalxpress.com/news/2012-01-dabigatran-acute-coronary-events.html Cardiology Mon, 09 Jan 2012 17:00:01 EST news245348574 Outpatient care for certain low-risk patients with pulmonary embolism (PE) can be safely and effectively used in place of inpatient care, according to a randomized, multi-center study in 19 emergency departments. The findings, published June 23 online in the Lancet, support current practice guidelines that are rarely followed by physicians. http://medicalxpress.com/news/2011-06-outpatient-treatment-safe-effective-low-risk.html Other Thu, 23 Jun 2011 14:52:33 EST news228059544